Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-06 · accession 0001510281-24-000279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-05-07 | 2024-05-06+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.74 | +60.9K | 3.08M | +2% | +$836.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-07 | P | A | 50,161 | $13.76 | 3,129,604 | I - | — | — | |
| 2 | Common | Common Stock | 2024-05-06 | P | A | 10,713 | $13.62 | 3,079,443 | I - | — | — |